Description
Description
This page contains brief details about the drug abacavir,lamivudine, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Abacavir and Lamivudine are antiretroviral medications containing the active constituents Abacavir and Lamivudine. Both medications belong to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs) and are often used in combination with other antiretroviral drugs as part of highly active antiretroviral therapy (HAART) or combination antiretroviral therapy (cART). It is used to treat HIV-1 infection. HIV-1 is a virus known as the Human immunodeficiency virus, which targets and eradicates immune system cells, ultimately weakening the body’s defense against infections. If left untreated, it can result in death. While this medication does not offer a complete cure, it effectively lowers the virus levels in your body and boosts the count of CD4 cells in your bloodstream. These cells play a crucial role in assisting your body’s fight against infections. The initial FDA approval date for abacavir was December 17, 1998; lamivudine was November 17, 1995.
Mechanism of Action of Abacavir+Lamivudine
Abacavir and lamivudine work by inhibiting the reverse transcriptase enzyme, which is necessary for the replication of HIV. By blocking this enzyme, the drugs help reduce the viral load in the body, slow the progression of HIV infection, and improve the immune system’s function.
Uses of Abacavir+Lamivudine
Abacavir and Lamivudine are used in the treatment of HIV-1 infection.
Abacavir+Lamivudine Dosage available
To use Abacavir and Lamivudine, follow your healthcare provider’s prescribed dosage and instructions. Take the medications as directed, usually orally, with or without food. Do not skip doses or stop taking them without consulting your healthcare provider. Consult your healthcare provider or pharmacist for guidance if you have any questions or concerns.
